The Enterprise Value as of December 2025 (TTM) for Everest Medicines Limited (1952.HK) is 15.08B

According to Everest Medicines Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 15.08B. This represents a change of 8.43% compared to the average of 13.91B of the last 4 quarters.

Everest Medicines Limited (1952.HK) Historical Enterprise Value (quarterly & annually)

How has 1952.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Everest Medicines Limited over the last ten years is 10.73B. The current 15.08B Enterprise Value has changed 13.95% with respect to the historical average. Over the past ten years (40 quarters), 1952.HK's Enterprise Value was at its highest in in the March 2019 quarter at 29.73B. The Enterprise Value was at its lowest in in the September 2022 quarter at 2.06B.

Everest Medicines Limited (1952.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Everest Medicines Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Everest Medicines Limited (1952.HK) Average Enterprise Value

How has 1952.HK Enterprise Value performed in the past?

The current Enterprise Value of Everest Medicines Limited (1952.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Everest Medicines Limited (1952.HK) Enterprise Value vs. Peers

How is 1952.HK’s Enterprise Value compared to its peers?

Everest Medicines Limited’s Enterprise Value is greater than Keymed Biosciences Inc. (14.72B), greater than Guangzhou Innogen Pharmaceutl Grp Co Ltd (14.69B), greater than Zai Lab Limited (1.43B), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (16.02B), less than Nanjing Leads Biolabs Co Ltd (0), greater than CStone Pharmaceuticals (7.89B), greater than InnoCare Pharma Limited (12.67B), greater than CARsgen Therapeutics Holdings Limited (6.40B), greater than CanSino Biologics Inc. (11.92B), less than Ascentage Pharma Group International (19.01B),

Build a custom stock screener for Everest Medicines Limited (1952.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Everest Medicines Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Everest Medicines Limited (1952.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Everest Medicines Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.